A detailed history of Westpac Banking Corp transactions in Abb Vie Inc. stock. As of the latest transaction made, Westpac Banking Corp holds 19,248 shares of ABBV stock, worth $3.37 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares
19,248
Previous 18,544 3.8%
Holding current value
$3.37 Million
Previous $3.18 Billion 19.51%
% of portfolio
0.25%
Previous 0.25%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$163.84 - $199.33 $115,343 - $140,328
704 Added 3.8%
19,248 $3.8 Billion
Q2 2024

Aug 14, 2024

BUY
$154.79 - $180.76 $2.53 Million - $2.96 Million
16,348 Added 744.44%
18,544 $3.18 Billion
Q2 2024

Aug 12, 2024

SELL
$154.79 - $180.76 $2.22 Million - $2.59 Million
-14,324 Reduced 86.71%
2,196 $3.18 Billion
Q1 2024

May 09, 2024

SELL
$159.82 - $182.1 $602,521 - $686,517
-3,770 Reduced 18.58%
16,520 $3.01 Billion
Q4 2023

Feb 08, 2024

SELL
$137.6 - $154.97 $1.92 Million - $2.16 Million
-13,962 Reduced 40.76%
20,290 $3.14 Billion
Q3 2023

Nov 09, 2023

BUY
$133.59 - $154.65 $2.74 Million - $3.17 Million
20,485 Added 148.8%
34,252 $5.11 Billion
Q2 2023

Aug 10, 2023

SELL
$132.51 - $164.9 $22.1 Million - $27.5 Million
-166,724 Reduced 92.37%
13,767 $1.85 Billion
Q1 2023

May 03, 2023

SELL
$144.61 - $166.54 $695,429 - $800,890
-4,809 Reduced 2.6%
180,491 $28.8 Billion
Q4 2022

Feb 06, 2023

BUY
$138.31 - $165.87 $22,682 - $27,202
164 Added 0.09%
185,300 $29.9 Billion
Q3 2022

Nov 08, 2022

BUY
$134.21 - $153.93 $40,934 - $46,948
305 Added 0.17%
185,136 $24.8 Billion
Q2 2022

Aug 10, 2022

BUY
$137.62 - $174.96 $847,326 - $1.08 Million
6,157 Added 3.45%
184,831 $28.3 Billion
Q1 2022

May 11, 2022

SELL
$131.98 - $163.75 $293,523 - $364,180
-2,224 Reduced 1.23%
178,674 $29 Million
Q4 2021

Feb 08, 2022

BUY
$107.43 - $135.93 $163,508 - $206,885
1,522 Added 0.85%
180,898 $24.5 Billion
Q3 2021

Oct 27, 2021

SELL
$106.4 - $120.78 $1.81 Million - $2.06 Million
-17,018 Reduced 8.67%
179,376 $19.3 Million
Q2 2021

Aug 11, 2021

SELL
$105.21 - $117.21 $489,962 - $545,846
-4,657 Reduced 2.32%
196,394 $22.1 Million
Q1 2021

May 13, 2021

SELL
$102.3 - $112.62 $5,933 - $6,531
-58 Reduced 0.03%
201,051 $21.8 Million
Q4 2020

Feb 11, 2021

SELL
$80.49 - $108.67 $331,135 - $447,068
-4,114 Reduced 2.0%
201,109 $21.5 Million
Q3 2020

Nov 10, 2020

BUY
$85.91 - $100.83 $65,377 - $76,731
761 Added 0.37%
205,223 $18 Million
Q2 2020

Aug 12, 2020

BUY
$73.37 - $98.18 $2.46 Million - $3.29 Million
33,556 Added 19.63%
204,462 $20.1 Million
Q1 2020

May 14, 2020

BUY
$64.5 - $97.79 $387,451 - $587,424
6,007 Added 3.64%
170,906 $13 Million
Q4 2019

Feb 11, 2020

SELL
$72.13 - $90.25 $238,028 - $297,825
-3,300 Reduced 1.96%
164,899 $14.6 Million
Q3 2019

Nov 13, 2019

SELL
$62.98 - $75.72 $724,144 - $870,628
-11,498 Reduced 6.4%
168,199 $12.7 Million
Q2 2019

Aug 01, 2019

BUY
$65.7 - $83.98 $606,936 - $775,807
9,238 Added 5.42%
179,697 $0
Q1 2019

May 14, 2019

BUY
$77.14 - $90.79 $4.83 Million - $5.68 Million
62,579 Added 58.01%
170,459 $0
Q4 2018

Feb 07, 2019

SELL
$77.85 - $96.01 $258,929 - $319,329
-3,326 Reduced 2.99%
107,880 $9.95 Million
Q3 2018

Nov 13, 2018

SELL
$88.91 - $98.84 $334,835 - $372,231
-3,766 Reduced 3.28%
111,206 $0
Q2 2018

Jul 18, 2018

BUY
$89.78 - $106.23 $324,734 - $384,233
3,617 Added 3.25%
114,972 $0
Q1 2018

May 01, 2018

BUY
$92.01 - $123.21 $728,995 - $976,192
7,923 Added 7.66%
111,355 $0
Q4 2017

Jan 18, 2018

BUY
$89.56 - $98.21 $35,824 - $39,284
400 Added 0.39%
103,432 $0
Q3 2017

Oct 30, 2017

BUY
$69.85 - $89.22 $7.2 Million - $9.19 Million
103,032
103,032 $0

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Westpac Banking Corp Portfolio

Follow Westpac Banking Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Westpac Banking Corp, based on Form 13F filings with the SEC.

News

Stay updated on Westpac Banking Corp with notifications on news.